Robot Assisted Gait Training for Physical Disabilities

N/A

Recruiting

Led By Elizabeth G Condliffe, MD, PhD

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 4 weeks.

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to evaluate the effects of using a robotic gait trainer called Trexo on rehabilitation and compensating for impairments. The study will assess how different settings on the Trexo impact physical activity

Who is the study for?

This trial is for individuals with physical disabilities, including cerebral palsy and developmental disabilities. Participants will be fitted to a Trexo robotic gait trainer and must be comfortable using it. The study requires three visits but offers additional sessions if desired.

What is being tested?

The study tests the effects of a single session of robot-assisted gait training using the Trexo device in different modes: 'endurance' where the robot does more work, and 'strength' where participants contribute more effort. It explores how these settings affect rehabilitation outcomes.

What are the potential side effects?

While not explicitly mentioned, potential side effects may include muscle fatigue, discomfort from equipment use, or skin irritation at contact points with the robotic trainer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 4 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 4 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 4 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Heart Rate Response to Exercise

Secondary study objectives

Average Number of Steps per Minute

Brain Region Activation

Characteristics of Gait / Walking Pattern

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Voluntary activity "Strength"Active Control1 Intervention

Participants will complete a training session using the Trexo robotic gait trainer in the "strength" mode where the gait pattern is impacted by the participant's activity

Group II: Passive "Endurance"Active Control1 Intervention

Participants will complete a training session using the Trexo robotic gait trainer in the "endurance" mode with a fixed gait pattern regardless of the participant's activity.

Do I qualify?Apply below to find out